INmune Bio GAAP EPS of -$0.20 beats by $0.04
Source: SeekingAlpha
2026-05-07 17:10:29 ET
More on INmune Bio
- INmune Bio Inc. (INMB) Q4 2025 Earnings Call Transcript
- INmune Bio Inc. (INMB) Discusses XPro1595 Phase II MINDFuL Results and Registrational Strategy in Alzheimer's Disease Transcript
- INmune Bio Inc. (INMB) Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB Transcript
- INmune Bio Q1 2026 Earnings Preview
- INmune Bio FY 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
INmune Bio GAAP EPS of -$0.20 beats by $0.04
INmune Bio Inc.
NASDAQ: INMB
INMB Trading
12.2% G/L:
$1.655 Last:
3,518,288 Volume:
$1.59 Open:
INMB Latest News
May 14, 2026 08:00:00 am
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
May 13, 2026 08:00:00 am
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
May 07, 2026 04:00:00 pm
INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
INMB Stock Data
$100,001,939
20,608,626
3.69%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Boca Raton
